SYNRIBO: Lyophilisate for solution for injection (3.5mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
OMACETAXINE (OH ma se TAX een) is a chemotherapy drug. This medicine is used to treat chronic myelogenous leukemia.
SYNRIBO 3.5mg Powder for Injection
NDC: 634590177-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Chronic Myelogenous Leukemia (CML)
Protect from light
Store in carton until time of use
Discard unused portion. Do not store for later use.
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Reported Side Effects for SYNRIBO 3.5mg Powder for Injection
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


